Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Diuretics can cause serious side effects and should be used carefully.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Hesperidin helps protect against testicular damage caused by finasteride.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Cyclosporine may cause hair loss, so patients need monitoring.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Acyzol could help treat conditions caused by zinc deficiency.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.